DUBLIN--(BUSINESS WIRE)--The "Smart Inhalers Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering. The report ...

Emerging opportunities in the global smart inhalers market include advances in digital health, technological innovation, and evolving regulatory scenarios. Strategic growth is driven by segmentation ...

Two Minneapolis-based companies – digital health care management program maker HealthFactors and medical-focused R&D firm Koronis BioMedical Technologies (KBT) – are working together to create new ...

New Zealand-based medical device company Nexus6 has received FDA clearance for its smartphone-connected inhaler, SmartTouch, as a class II medical device. The new SmartTouch device has been cleared as ...

DUBLIN--(BUSINESS WIRE)--The "Smart Inhalers Market to 2027 - Global Analysis and Forecasts by Product; Disorder; End User and Geography" report has been added to ResearchAndMarkets.com's offering.

ATS 2024, San Diego – Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and ...

LONDON (Reuters) - Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers ...

MILAN -- An electronic monitoring device (EMD) increased adherence to asthma medication in the short-term but still left patients needing more assistance in the long run, a cluster-randomized trial ...

RYAH Medtech, Inc. subsidiary of RYAH Group, Inc. RYAH has received a Health Canada medical device license for its proprietary internet of things powered medical cannabis inhaler, proprietary ...

Santa Ana, California-based startup Cognita Labs has won FDA clearance for its first device, a smart cap for inhalers used by people with asthma, chronic obstructive pulmonary disease and other ...

Only 14.5% of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40% of academic pulmonary and allergy clinicians have not adopted ...